Ifp Advisors, Inc Acelrx Pharmaceuticals Inc Transaction History

Ifp Advisors, Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 06, 2021	SELL	$0.93 - $1.51 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$1.03 - $1.7 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$1.25 - $2.77 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	BUY	$1.18 - $1.98 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	BUY	$1.01 - $1.81 $0 - $0	0 New	0 $0
Q2 2020 Aug 05, 2020	BUY	$1.03 - $1.69 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	SELL	$0.76 - $2.07 $608 - $1,655	-800 Closed	0 $0
Q4 2019 Jan 17, 2020	BUY	$1.66 - $2.4 $1,328 - $1,920	800 New	800 $2,000
Q3 2018 Oct 25, 2018	SELL	$2.6 - $4.6 $51,157 - $90,509	-19,676 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$2.13 - $4.2 $37,649 - $74,239	17,676 Added 883.8%	19,676 $0
Q1 2018 May 09, 2018	BUY	$1.7 - $2.35 $3,349 - $4,629	1,970 Added 6566.67%	2,000 $0
Q2 2016 Jun 03, 2019	BUY	N/A	30	30 $0

Ticker ACRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 7,366,600
Market Cap $8.32M
Description
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. Its lead product candidate is DSUVIA and DZUVEO, a 30 mcg sufentanil sublingual tablet for the treatment of moderate-to-severe acute pain. The company develops ZALVISO, a pre-programmed ...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.